Filing Details
- Accession Number:
- 0001641172-25-021930
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-01 17:00:19
- Reporting Period:
- 2025-07-30
- Filing Date:
- 2025-08-01
- Accepted Time:
- 2025-08-01 17:00:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1433607 | Inspiremd Inc. | NSPR | Surgical & Medical Instruments & Apparatus (3841) | 262123838 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1528577 | Paul Stuka | C/O Inspiremd, Inc. 6303 Waterford District Drive, Suite 215 Miami FL 33126 | Yes | No | No | No |
Transaction Summary
Purchased: | 20,661 shares | Avg. Price: $2.42 | Total Value: $49,999.62 |
Number of Shares After Transactions: | 444,195 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-07-30 | 20,661 | $2.42 | 444,195 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 360,284 | Direct |
Footnotes
- The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").
- The purchase price per share of common stock in the Private Placement was $2.42.
- These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.